BCL3 and metabolic dysfunction-associated steatohepatitis: Conversely, hepatocyte-specific overexpression of Bcl3 exacerbates non-alcoholic steatohepatitis (NASH) by promoting hepatic steatosis, inflammation, and insulin resistance [20].